Methicillin-Resistant Staphylococcus Aureus (MRSA): Difference between revisions
(Text replacement - "==Source==" to "==References==") |
|||
(19 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{MRSA background}} | |||
== | ==Management== | ||
*Treatment/resistance is different for each type; check specific page | |||
== | ==Table Overview== | ||
{{Clinically Relevant Bacteria}} | |||
== | ==See Also== | ||
*[[Microbiology (Main)]] | |||
*[[Staph. aureus]] | |||
==References== | |||
==References== | |||
<references/> | |||
[[Category:ID]] | [[Category:ID]] |
Latest revision as of 21:30, 10 September 2017
Background
- Two kinds of MRSA:
- Hospital acquired-MRSA (HA-MRSA)
- Multi-drug resistant, most commonly seen in ventilator associated pneumonia, post operative infections, and catheter associated infections
- Community acquired-MRSA (CA-MRSA)
- Tends to be resistant to beta-lactams, most commonly seen in Skin and Soft Tissue Infections and rarely in necrotizing pneumonia
- Hospital acquired-MRSA (HA-MRSA)
Risk Factors
- Multiple skin sites
- Recurrent infection
- Close contact of person with Hx of MRSA
- Infection showing early necrosis
Management
- Treatment/resistance is different for each type; check specific page
Table Overview
|